Advertisement
News
Advertisement

480 Biomedical starts human trial

Mon, 04/16/2012 - 10:32am
Mass High Tech: The Journal of New England Technology

Arsenal Medical spinout 480 Biomedical Inc. of Watertown said it has started the first human trial of a bioresorbable scaffold aimed at treating peripheral artery disease by restoring blood flow to the leg.

SOURCE

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading